Data Snapshot: Aug 04, 2026
$500K+

Jul-2026

Sales

Decline

Trend

6-Month

122

Product Count

SKUs

$16.95

Avg Price

-56%

YoY Sales Change

-7.8%

YoY Price Change

LEVEL is a renowned, privately-owned cannabis company that stands at the vanguard of cannabinoid research and innovation, formulating targeted, effects-based cannabis experiences. Distinguished by their advanced understanding and application of cannabinoids and terpenoids, Level I cultivators are granted permission to initiate marijuana cultivation, meeting rigid security requirements for site research. While fully committed to consumer safety measures, the company also facilitates a comprehensive understanding of cannabis, offering reliable information about the differences between THC and CBD, the health implications, and the company's diverse cannabis strains.
Level

Where to Buy

Level is stocked at 910 licensed dispensaries across California, New York, and 7 other states, 588 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, San Francisco, and Santa Rosa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/2292.json?v=20260804
Level Sales

Market Insights Snapshot

Level Historical Sales by Category

Capsules accounted for 99.92% share in July 2026 with a year-over-year change of -56.06% and month-over-month change of -3.40%, while Flower held 0.08% share with a year-over-year change of 3,181.96% and month-over-month change of 45.26%. The average price fell 7.81% year over year to $16.95, aligning with a 56.03% brand sales contraction year over year and a 72.80% decline over 24 months. With Capsules concentrated at 99.92% share and rank 2 in Capsules in Nevada, the pattern implies a highly specialized portfolio where small but rapid gains in Flower do not yet offset the sustained volume erosion in the core format.

The 45.26% month-over-month increase and 3,181.96% year-over-year surge in Flower from a 0.08% base, alongside a -3.40% month-over-month dip and -56.06% year-over-year decline in Capsules, indicates portfolio fragility if Capsules continue to contract. Given average pricing down 7.81% year over year and Capsules at a 99.92% share, maintaining rank 2 in Capsules in Nevada while diversifying into a higher-priced Flower line at $29.52 suggests Level is trading some price for volume in its core and probing premium positioning at the margin; the implication is a need to rebalance mix to stabilize share without overreliance on a single format.

Jul-2026 Rank
Capsules
4
2
2
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
99.9%
$16.94
-56.1%
-3.4%
Flower
0.1%
$29.52
+3182.0%
+45.3%
Level

Competitive Landscape

Level sits at rank #4 in California Capsules in July 2026, down 3 positions from #1 year over year, and off 2 places from April 2026’s #2, while having previously peaked at #1 in January 2026; in contrast, Breez holds #1 despite a -32.37% year-over-year sales change and ABX / AbsoluteXtracts is #3 with a -6.98% year-over-year decline, whereas Emerald Bay Extracts climbed to #2 from #5 year over year on a +40.61% lift; this pattern implies Level’s rank trajectory has shifted from a January 2026 leadership position toward a mid-pack posture as competitors with either recovering or contracting sales dynamics re-ordered the top three.

Level market ranking for CA Capsules

Level

Notable Products

Hashtab 100 - Indica Tablet (100mg) delivered the standout move in July 2026 with a 56.5% month-over-month gain into rank 4, while Protab+ - Lights Out Tablets 10-Pack (50mg CBN, 20mg CBG, 200mg Delta-9 THC, 50mg Delta-8 THC, 20mg THCA) fell 38.8% to rank 5. Protab - Sativa Profesional Strength Tablet (100mg) declined 15.5% to rank 2 as Protab - Indica Tablet (100mg) inched up 4.4% at rank 1, indicating a tilt toward indica-led formats over sativa in the month. With all ten top sellers in Capsules and four SKUs clustered in the top six despite mixed movements ranging from +56.5% to -38.8%, the concentration implies Level is consolidating around pill-based dosing rather than dispersing into other form factors.

Product
Category
Mar-2026
Apr-2026
May-2026
Jun-2026
Jul-2026
MoM %
Protab - Indica Tablet (100mg)
Capsules
1
1
1
1
1
+4.4%
Protab - Sativa Profesional Strength Tablet (100mg)
Capsules
2
2
2
2
2
-15.5%
Protab - Sativa Extra Strength Tablets 10-Pack (250mg)
Capsules
4
3
3
4
3
+8.3%
Hashtab 100 - Indica Tablet (100mg)
Capsules
>10
10
>10
10
4
+56.5%
Protab+ - Lights Out Tablets 10-Pack (50mg CBN, 20mg CBG, 200mg Delta-9 THC, 50mg Delta-8 THC, 20mg THCA)
Capsules
3
4
4
3
5
-38.8%
Protab - Indica Extra Strength Tablets 10-Pack (250mg)
Capsules
5
5
8
5
6
-0.9%
Hashtab 100 - Sativa Tablet (100mg)
Capsules
10
9
7
7
7
-1.7%
Protab Max - Indica Strength Tablet 2-Pack (100mg)
Capsules
8
>10
>10
9
8
-8.6%
Protab+ - THC/THCv/CBG Boost Tablets 10-Pack (200mg THC, 70mg THCv, 30mg CBG)
Capsules
9
7
5
8
9
+3.3%
Hashtab - Indica Tablets 10-Pack (250mg)
Capsules
6
6
6
6
10
-7.7%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market